Corporate Supporters
Medtronic
Medtronic is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world. During the past year, Medtronic provided medical professionals with products and therapies to improve the lives of more than 5 million patients. Primary products include those for heart and vascular disease, neurological disorders, chronic pain, spinal disorders, diabetes, urologic and digestive system disorders, and eye, ear, nose and throat disorders.
AstraZeneca
AstraZeneca is an international pharmaceutical company that provides medicines designed to treat diseases in important areas of medical need: oncology, cardiovascular, gastrointestinal, infection, neuroscience and respiratory. (Source: AstraZeneca)
Pharma Dynamics
Pharma Dynamics is committed to providing all South Africans with access to effective affordable healthcare. (Source: Pharma Dynamics)
Boston Scientific
Boston Scientific: Our products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women’s health, and chronic pain conditions. (Source: Boston Scientific)
Novartis
Novartis provides healthcare solutions that address the evolving needs of patients and societies. We are a world leader in healthcare, with core businesses in pharmaceuticals, consumer health, animal health, eye care and generics. (Source: Novartis)
Vertice MedTech
Your Premium Medtech Partner
Established in 2018, following a strategic partnership between The Amayeza Group and South Africa-based investor, Ethos, Vertice is committed to bringing the best-in-class medical technologies to enable healthcare professionals to provide optimal care to their patients.
Our customers love working with us because we produce high-quality, world-class surgical products and instruments, personalised service, extensive training and comprehensive technical support.
Boehringer Ingelheim
Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company
Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health,
Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885,
Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017,
Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales.
As a family-owned company,
Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does,
Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment. (Source:
Boehringer Ingelheim)
Cipla
Cipla has been built brick by brick on the foundation of Care. We are driven by this purpose – a purpose that is more than 8 decades young and it lies at the center of all our thoughts and plans, driving our actions. In being purpose inspired, we look at actions and solutions that are sustainable and lead to ‘Caring for Life’.
We are a global pharmaceutical firm that consistently Cares for Life and delivers on its commitment to all our stakeholders – patients, regulators, customers, partners, employees, investors and community.
